Andon Health Co., Ltd. (SHE:002432)
China · Delayed Price · Currency is CNY 76.13
-2.17 (-2.77%)
May 8, 2026, 3:04 PM CST
Andon Health Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 2,294 | 2,267 | 1,669 | 1,252 | 16,030 | 908.64 |
Depreciation & Amortization | 56.46 | 56.46 | 65.57 | 105.17 | 106.05 | 89.36 |
Other Amortization | 24.67 | 24.67 | 2.52 | 2.45 | 36.95 | 7.61 |
Loss (Gain) From Sale of Assets | 0.01 | 0.01 | -0.67 | 0.5 | 6.43 | -0.01 |
Asset Writedown & Restructuring Costs | 5.32 | 5.32 | 25.45 | 242.65 | 172.22 | 1.88 |
Loss (Gain) From Sale of Investments | -2,832 | -2,832 | -1,448 | -870.03 | 232.92 | -74.25 |
Provision & Write-off of Bad Debts | -2.76 | -2.76 | 2.63 | -2.67 | 12.59 | 23.43 |
Other Operating Activities | 18.64 | 145.68 | 223.23 | 208.5 | 620.88 | 46.51 |
Change in Accounts Receivable | -28.2 | -28.2 | 2.97 | 401.76 | 353.29 | -718.62 |
Change in Inventory | 4.78 | 4.78 | 197.13 | 400.22 | -220.92 | -332.14 |
Change in Accounts Payable | -78.85 | -78.85 | 89.38 | -279.88 | -196.62 | 361.91 |
Change in Other Net Operating Assets | 192.91 | 192.91 | 86.38 | 220.92 | 185.32 | 9.17 |
Operating Cash Flow | -266.59 | -166.8 | 986.75 | 1,770 | 18,222 | 293.11 |
Operating Cash Flow Growth | - | - | -44.26% | -90.29% | 6116.59% | -36.50% |
Capital Expenditures | -314.52 | -264.33 | -73.92 | -212.65 | -211.9 | -70.45 |
Sale of Property, Plant & Equipment | 1.1 | 2.37 | 0.86 | 0.58 | 0.46 | 0.1 |
Cash Acquisitions | -1.87 | -0.96 | - | - | - | - |
Divestitures | - | - | - | -7.2 | - | - |
Investment in Securities | -1,895 | -688.16 | 3,663 | -4,214 | -12,798 | -345.66 |
Other Investing Activities | 1,763 | 1,102 | 595.47 | 247.35 | 66.11 | 58.78 |
Investing Cash Flow | -1,326 | -728.45 | -581.27 | -4,186 | -12,943 | -357.22 |
Short-Term Debt Issued | - | - | - | - | - | 237.12 |
Long-Term Debt Issued | - | 9,122 | 3,603 | 1,529 | 256.75 | - |
Total Debt Issued | 12,493 | 9,122 | 3,603 | 1,529 | 256.75 | 237.12 |
Short-Term Debt Repaid | - | - | - | - | - | -253.62 |
Long-Term Debt Repaid | - | -6,835 | -1,864 | -290.02 | -349.68 | -24.3 |
Total Debt Repaid | -9,558 | -6,835 | -1,864 | -290.02 | -349.68 | -277.92 |
Net Debt Issued (Repaid) | 2,935 | 2,288 | 1,739 | 1,239 | -92.93 | -40.8 |
Issuance of Common Stock | 10.6 | 10.6 | 394.89 | 24.44 | 139.14 | 342.64 |
Repurchase of Common Stock | -995.02 | -995.02 | -1,198 | -1,000 | - | -199.84 |
Common Dividends Paid | -191.52 | -186.91 | -190.66 | -1,187 | -322.03 | -36.68 |
Other Financing Activities | -269.94 | -592.47 | -649.18 | - | - | -0.33 |
Financing Cash Flow | 1,489 | 523.69 | 96.21 | -922.78 | -275.82 | 65 |
Foreign Exchange Rate Adjustments | -113.47 | -71.08 | 43.94 | 69.44 | 15.8 | -14.24 |
Net Cash Flow | -217.9 | -442.63 | 545.63 | -3,269 | 5,018 | -13.35 |
Free Cash Flow | -581.12 | -431.13 | 912.83 | 1,557 | 18,010 | 222.67 |
Free Cash Flow Growth | - | - | -41.39% | -91.35% | 7988.15% | -45.41% |
Free Cash Flow Margin | -50.09% | -31.57% | 35.22% | 48.20% | 68.44% | 9.29% |
Free Cash Flow Per Share | -1.35 | -0.99 | 2.07 | 3.44 | 38.53 | 0.49 |
Cash Income Tax Paid | 187.78 | 194.89 | 105.24 | 40.86 | 1,009 | -15.62 |
Levered Free Cash Flow | -348.49 | -279.18 | 770.39 | 1,144 | 11,554 | -4.26 |
Unlevered Free Cash Flow | -270.81 | -208.23 | 812.37 | 1,152 | 11,557 | 4.05 |
Change in Working Capital | 169 | 169 | 447.36 | 831.94 | 1,003 | -710.06 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.